Clinical trial
Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy…
NCT00231712 · Julius-Maximilians University, Other · Unknown status
Key facts
| NCT number | NCT00231712 |
|---|---|
| Title | Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant |
| Official title | Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant |
| Lead sponsor | Julius-Maximilians University, Other |
| Collaborators | University of Wuerzburg |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Leukemia, Medulloblastoma |
| Enrollment | 50 |
| Start date | Mar 1, 2005 |
| Completion | Feb 1, 2009 |
| First posted | Oct 4, 2005 |
| Last update posted | Aug 23, 2006 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: